Treatment News : Scientists Devise Method of Snipping HIV From Immune Cells

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2014

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 24, 2014

Scientists Devise Method of Snipping HIV From Immune Cells

Researchers have created a genetic treatment that, for the first time, has succeeded in removing HIV from infected human cells, providing hope that the technique may be used as part of a treatment, cure or vaccine for the virus. Publishing their findings in the Proceedings of the National Academy of Sciences, researchers devised molecular tools that delete HIV proviral DNA from infected cells.

When HIV infects a human cell, it integrates its DNA into the cell. The new technique takes what’s known as a “guide RNA,” or gRNA, which hunts down the virus’s genetic material, and pairs it with an enzyme called a nuclease that snips DNA out of the cell. The cell’s own methods of repairing genes then kick into gear, bringing the loose ends of the spliced genome back together. The result: a virus-free cell.

The process succeeded in removing the virus from various types of immune cells that HIV typically targets, including microglia, macrophages and CD4 cells.

To make sure the gRNA, which was built from 20 nucleotides (the basic building blocks of the genetic code), did not wind up integrated into the cell’s genome, the researchers constructed it from sequences that do not appear in the coding sequences of human DNA. This helped avoid any cell DNA damage and mitigated the risk of adverse effects.

“This is one important step on the path toward a permanent cure for [HIV],” study co-lead researcher Kamel Khalili, PhD, professor and chair of the department of neuroscience at Temple University in Philadelphia, said in a release.

The technique might be able to fight other viruses and could be used for an HIV vaccine, since cells that were protected by the combination of the nuclease and gRNA could not be infected.

“It’s an exciting discovery, but it’s not yet ready to go into the clinic. It’s a proof of concept that we’re moving in the right direction,” study co-lead researcher Wenhui Hu, MD, PhD, associate professor of neuroscience at Temple, said in the release.

A next step is to find a way to deliver the therapy to every infected cell. Also, because of HIV’s vast capacity to mutate, therapies may need to be tailored to a person’s particular viral gene sequences.

To read the press release, click here.

To read the study abstract, click here.

Search: Genetic editing, snip, HIV, DNA, guide RNA, gRNA, nuclease, enzyme, Temple University, Kamel Khalili, Wenhui Hu, Proceedings of the National Academy of Sciences.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (10 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.